Nursing home residents received updated monovalent SARS-CoV-2 vaccines to protect against emerging variants. This study assessed the level and durability of clinical protection after the first KP.2 monovalent dose.
Nursing home residents received updated monovalent SARS-CoV-2 vaccines to protect against emerging variants. This study assessed the level and durability of clinical protection after the first KP.2 monovalent dose.